methylphenidate has been researched along with Malignant Melanoma in 4 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the effect of exercise and methylphenidate on fatigue, functional ability, and cognitive function in patients with melanoma." | 7.71 | Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. ( Masood, N; Schwartz, AL; Thompson, JA, 2002) |
| " We report a case of severe protracted depression induced by IFN in a patient diagnosed with melanoma who responded rapidly to a course of methylphenidate using the Hamilton Depressive Rating Scale." | 3.73 | Methylphenidate for alpha-interferon induced depression. ( Camacho, A; Ng, B, 2006) |
| "To examine the effect of exercise and methylphenidate on fatigue, functional ability, and cognitive function in patients with melanoma." | 3.71 | Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. ( Masood, N; Schwartz, AL; Thompson, JA, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auyeung, SF | 1 |
| Long, Q | 1 |
| Royster, EB | 1 |
| Murthy, S | 1 |
| McNutt, MD | 1 |
| Lawson, D | 1 |
| Miller, A | 1 |
| Manatunga, A | 1 |
| Musselman, DL | 1 |
| Schwartz, AL | 1 |
| Thompson, JA | 1 |
| Masood, N | 1 |
| Camacho, A | 1 |
| Ng, B | 1 |
| Reineke-Bracke, H | 1 |
| Radbruch, L | 1 |
| Elsner, F | 1 |
4 other studies available for methylphenidate and Malignant Melanoma
| Article | Year |
|---|---|
Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy.
Topics: Behavioral Symptoms; Citalopram; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Doubl | 2009 |
Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate.
Topics: Adult; Aged; Antineoplastic Agents; Cancer Care Facilities; Central Nervous System Stimulants; Cogni | 2002 |
Methylphenidate for alpha-interferon induced depression.
Topics: Affect; Aged; Antineoplastic Agents; Central Nervous System Stimulants; Depressive Disorder; Humans; | 2006 |
Treatment of fatigue: modafinil, methylphenidate, and goals of care.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Fatigue; Female; Germany; Humans; Me | 2006 |